AMSTERDAM and PHILADELPHIA, June 25, 2018 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is highlighting its portfolio of molecular imaging solutions at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2018 Annual Meeting in Philadelphia, PA. With innovations such as Time-of-Flight PET and digital PET/CT, Philips is continuing to […]
Author: Ken Dropiewski
Stereotaxis and Johnson & Johnson’s Biosense Webster Extend Development Alliance and Supply Agreement
ST. LOUIS, June 25, 2018 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that it has entered into an amendment to the long-term Development Alliance and Supply Agreement with Johnson & Johnson’s Biosense Webster, Inc. The amendment […]
GPB Capital Enters into $21 Million Debt Investment in CardioFocus®
NEW YORK, June 22, 2018 /PRNewswire/ — GPB Capital has completed a debt investment in CardioFocus® Inc., which develops and manufactures products for the treatment of irregular heartbeats and other cardiac disorders. Proceeds from the investment will help CardioFocus commercially launch its next-generation HeartLight® Endoscopic Balloon Ablation System for the treatment of atrial […]
New Study Demonstrates Accuracy of Fully-Automated Ejection Fraction Calculation Using Bay Labs’ EchoMD AutoEF Software
Study Results Presented at American Society of Echocardiography Annual Scientific Sessions NASHVILLE, Tenn. – June 25, 2018 – Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) to cardiovascular imaging, today announced its EchoMD AutoEF deep learning software has less variability in evaluating left ventricular […]
Avinger’s Ocelot Technology Featured in Live Case Transmission at Complex Cardiovascular Catheter Therapeutics (C3) 2018
REDWOOD CITY, Calif., June 21, 2018 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that its Ocelot image-guided chronic total occlusion (CTO) crossing device was featured in a live case on June 19th at Complex Cardiovascular Catheter Therapeutics (C3) 2018 […]
Mercator MedSystems Receives $11M in Series D Equity Financing Led by Shenzhen Salubris Pharmaceuticals Co.
EMERYVILLE, Calif., June 21, 2018 /PRNewswire/ — Mercator MedSystems, Inc., today announced it has received $11 million in Series D equity financing led by Shenzhen Salubris Pharmaceuticals Co. (Salubris), with participation from current Mercator investors and other undisclosed new investors. The new funding will further advance the clinical development of Mercator’s proprietary micro-infusion catheter systems […]
REVA Extends Technological Lead in Bioresorbable Scaffolds With CE Mark Approval of the Full Fantom® Encore Product Line
SAN DIEGO, June 18, 2018 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, today announced it has received CE Mark approval for its full Fantom® Encore product line. This covers Fantom Encore in the 3.0 and 3.5 mm diameters, […]
Saranas Announces Scheduled Presentations at TVT 2018 in Chicago
HOUSTON–(BUSINESS WIRE)–Saranas Inc., a medical device company with innovative technology for real-time detection and monitoring of internal bleeding during endovascular procedures, has been invited to present at the Transcatheter Valve Therapies (TVT) Structural Heart Disease Summit, which will take place June 20-23 at the Sheraton Grand Chicago. Scheduled presentations of […]
PlaqueTec Sponsors and Presents Data at Vulnerable Patient Meeting
CAMBRIDGE, England–(BUSINESS WIRE)–PlaqueTec announced today that it will sponsor the exclusive Vulnerable Patient Meeting (VPM), taking place 24-26 June in Stresa, Italy, for the fourth time. VPM, hosted by Cardialysis, is an annual invitation-only meeting focused on atherosclerosis for approximately 75-100 attendees, with a faculty of cardiology opinion leaders, regulators, […]
Marina Biotech Appoints Robert Moscato to Chief Executive Officer
City of Industry, CA, June 20, 2018 (GLOBE NEWSWIRE) — Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of innovative therapeutics for hypertension, arthritis, pain and oncology, today announced that its Board of Directors has appointed Robert C. Moscato, Jr. to serve […]



